⚡ CLINICAL PROTOCOL MATCHING: October 8, 2026 • Single vs Dual Incretin Triage • Flat $79 or $129 503A Access Open
⚡ ⚡ 2026 Protocol Matcher Diagnostic

Which Incretin Protocol Fits Your Metabolism? (Semaglutide vs Tirzepatide)

Take this free 60-second clinical diagnostic to evaluate your BMI tier, gastrointestinal sensitivity, and weight reduction goals, and see whether single GLP-1 ($79/mo) or dual GIP/GLP-1 ($129/mo) is your ideal medical match.

⚠️ ACCESS ALERT: PROTOCOL SELECTION ALERT: While Semaglutide is the most studied GLP-1 peptide in clinical history, next-gen Tirzepatide activates both GIP and GLP-1 receptors, achieving up to 22.5% body weight reduction.
✓
Instant 60-Second Protocol Triage: Match your individual metabolism to the right clinical peptide.
✓
Compare Flat-Rate Pricing: Semaglutide locked at $79/mo vs Tirzepatide locked at $129/mo.
✓
US Physician Oversight: Consult with a board-certified doctor online to verify your prescription eligibility.
🟢 36,440 Protocol Matches Completed This Month • $0 Intake Fee
⚡ Question 1 of 10
10% Complete

What is your total target weight reduction goal over the next 6 to 12 months?

Helps match clinical efficacy tier to your personal objective: